A SNP in 3′ of STP (rs3025039) has been associated with decreased plasma levels of VEGF and decreased breast cancer risk [14]; however, neither this nor other SNPs in LD were associated with bladder cancer risk in our study. The gene discussed is VEGFA; the disease is urinary bladder cancer.